Attached files

file filename
8-K - 8-K - EBIX INCform8kq42017results.htm
Exhibit 99.1

ebixlogoa16.jpg

Ebix Q4 Revenue ROSE 31% TO $104.7M AND EPS ROSE 11% TO $0.84; Full Year Revenue Rose 22% to $364.0M and EPS Rose 11% to $3.17

JOHNS CREEK, GA - March 1, 2018 - Ebix, Inc. (NASDAQ: EBIX), a leading international supplier of On-Demand software and E-commerce services to the insurance, financial, e-governance and healthcare industries, today reported fiscal 2017 fourth quarter (Q4 2017) and full year results for the periods ended December 31, 2017. Ebix will host a conference call to review its results tomorrow, Friday March 2nd at 11:00 a.m. EST (details below).

Ebix delivered the following results for the fourth quarter and full year of 2017:

Revenue: Total Q4 2017 revenue rose 31% to $104.7 million, compared to $80.0 million in Q4 2016 and increased 13% over Q3 2017 revenue of $92.8 million.

Full year 2017 revenue rose 22% to $364.0 million, compared to $298.3 million in 2016. Exchanges including the EbixCash operations in India, continued to be Ebix’s largest channel, accounting for 79% of the Company's Q4 2017 and 71% of full year 2017 Revenue.

(dollar amounts in thousands)
 
 
 
 
Channel
Q4 2017
Q4 2016
Change
2017
2016
Change
Exchanges
$ 82,353
$ 55,003
+50%
$ 259,470
$ 206,427
+26%
Broker Systems
3,576
3,451
+4%
14,674
14,105
4%
Risk Compliance Solutions (RCS)
18,052
20,707
-13%
86,832
74,196
17%
Carrier Systems
700
885
-21%
2,995
3,566
-16%
Total Revenue
$104,681
$ 80,046
+31%
$ 363,971
$ 298,294
+22%
 
 
 
 
 
 
 
Total Revenue on Constant Currency Basis
$ 102.9M
$ 80.0M
+29%
$ 360.0M
$ 298.3M
+21%


Earnings per Share: Q4 2017 diluted EPS increased 11% to $0.84 from $0.76 in Q4 2016. Full year 2017 diluted EPS increased 11% to $3.17 from $2.86 in 2016. The improvements reflect higher net income and the benefit of previous share repurchase activity.

Operating Cash: Cash generated from operations decreased 13% to $26.7 million in Q4 2017, compared to $30.7 million in Q4 2016. Cash generated from operations decreased 8% to $76.8 million in 2017, compared to $83.7 million in 2016.

Operating Income and Margins: Q4 2017 operating margins were 32%, a decrease over Q4 2016 margins of 35%. Operating income for Q4 2017 rose 20% to $33.1 million compared to $27.7 million in Q4 2016.

Full year 2017 operating margins were at 31%. Operating income for 2017 rose 13% to $113.2 million as compared to $100.3 million in 2016.




Exhibit 99.1

Net Income: Q4 2017 net income rose 8% to $26.6 million, compared to $24.6 million in Q4 2016. Net income increased 7% to $100.6 million in 2017, compared to $93.8 million in 2016.

Share Outstanding and Repurchases: Ebix made no repurchases of its common stock in Q4 2017, and repurchased 687,048 shares of its common stock for cash consideration of $39.4 million in the full year 2017. Reflecting its repurchase activity, Ebix’s weighted average diluted shares outstanding decreased to 31.7 million in Q4 2017 compared to 32.5 million in Q4 2016 and decreased to 31.7 million in 2017 compared to 32.9 million in 2016.

Q1 & Q2 2018 Diluted Share Counts: Based on share repurchases completed to date, Ebix expects its diluted share count to be approximately 31.7 million in Q1 2018 and Q2 2018.

Dividend: Ebix paid its regularly quarterly dividend of $0.075 per share in Q4 2017 for a total cost of $2.4 million.

Ebix Chairman, and CEO Robin Raina said, “Our record 2017 results mark Ebix’s 18th consecutive year of revenue and EPS growth for the Company, supported by a strong finish to the year especially from EbixCash with record revenue and EPS in Q4 2017. With an annualized revenue run rate of $418 million, Ebix has a strong foundation from which to conquer new frontiers in terms of revenues, operating margins and EPS.”

Robin added, “We started the year 2017 primarily as an insurance exchange, and have finished the year with a strong presence in the financial exchange sector also through our EbixCash brand in India. Ebix’s Q4 2017 performance did not include full quarter revenues from the recent acquisition of Paul merchant remittance assets, or include any revenues from the recent acquisition of Transcorp, and only a few hundred thousand of revenues from our e-governance division which typically has a quarterly run rate of $6 million. Not withstanding these factors, Q4 2017 revenues from India operations and the EbixCash Financial Exchange translate to an annualized run rate of $127 million and $125 million respectively. Accordingly, we are encouraged by the momentum we have generated in these businesses in a short time.

“We are also pleased to have achieved 32% operating margins in Q4 2017, especially considering that the quarter had many non-recurring acquisition related costs. Once we have fully implemented all our acquisition integration and efficiency related measures, we expect the margins to improve from this level.”

Robin added, “We are in advance stages of review on several acquisition opportunities that have the potential to make material contributions to our 2018 results if we are able to complete these transactions on the contemplated terms. Also, we have executed a number of large new business contracts that are expected to start contributing to our top line in 2018. As a result of our strong business development activity and pipeline, combined with expected organic growth across the business, we believe Ebix is well positioned for another solid year in 2018.”

Sean Donaghy, Ebix’s CFO said “Ebix continues to produce robust operating cash flows, generating $26.7 million during Q4 of 2017 and $76.8 million during 2017. Our financial position remains strong with $89.5 million in aggregate cash, cash equivalents, and short-term cash deposit investments. Combined with available borrowing of $246 million under our syndicated bank facility, Ebix presently has access to approximately $331 million of capital to support continued organic and acquisitive growth as well as dividends and opportunistic share repurchases.”


Conference Call Details:




Exhibit 99.1

Call Date/Time:
Friday, March 2, 2018 at 11:00 a.m. EST
Call Dial-In:
+1-877-837-3909 or 1-973-409-9690; Call ID #1064759
Live Audio Webcast:
www.ebix.com/webcast
Audio Replay URL:
www.ebix.com/result_17_Q4 after 2:00 p.m. EST on Mar 2nd 


About Ebix, Inc.

With 50+ offices across 5 continents, Ebix, Inc., (NASDAQ: EBIX) endeavors to provide On-Demand software and E-commerce services to the insurance, financial and healthcare industries. In the Insurance sector, the Company’s main focus is to develop and deploy a wide variety of insurance and reinsurance exchanges on an on-demand basis, while also, providing Software-as-a-Service ("SaaS") enterprise solutions in the area of CRM, front-end & back-end systems, outsourced administrative and risk compliance, across the world.

With a "Phygital” strategy that combines 231,500 physical distribution outlets in many Southeast Asian Nations (“ASEAN”) countries to an Omni-channel online digital platform, the Company’s EbixCash Financial exchange portfolio encompasses leadership in areas of domestic & international money remittance, travel, pre-paid & gift cards, utility payments, etc., in an emerging country like India. EbixCash, through its travel portal Via.com, is also one of Southeast Asia’s leading travel exchanges with over 110,000 distribution outlets and 8,000 corporate clients processing over 24.5 million transactions every year

Through its various SaaS-based software platforms, Ebix employs thousands of domain-specific technology professionals to provide products, support and consultancy to thousands of customers on six continents. For more information, visit the Company’s website at


SAFE HARBOR REGARDING FORWARD-LOOKING STATEMENTS

As used herein, the terms “Ebix,” “the Company,” “we,” “our” and “us” refer to Ebix, Inc., a Delaware corporation, and its consolidated subsidiaries as a combined entity, except where it is clear that the terms mean only Ebix, Inc.

The information contained in this Press Release contains forward-looking statements and information within the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. This information includes assumptions made by, and information currently available to management, including statements regarding future economic performance and financial condition, liquidity and capital resources, acceptance of the Company’s products by the market, and management’s plans and objectives. In addition, certain statements included in this and our future filings with the Securities and Exchange Commission (“SEC”), in press releases, and in oral and written statements made by us or with our approval, which are not statements of historical fact, are forward-looking statements. Words such as “may,” “could,” “should,” “would,” “believe,” “expect,” “anticipate,” “estimate,” “intend,” “seeks,” “plan,” “project,” “continue,” “predict,” “will,” “should,” and other words or expressions of similar meaning are intended by the Company to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are found at various places throughout this report and in the documents incorporated herein by reference. These statements are based on our current expectations about future events or results and information that is currently available to us, involve assumptions, risks, and uncertainties, and speak only as of the date on which such statements are made.

Our actual results may differ materially from those expressed or implied in these forward-looking statements. Factors that may cause such a difference, include, but are not limited to those discussed in our Annual



Exhibit 99.1

Report on Form 10-K and subsequent reports filed with the SEC, as well as: the risk of an unfavorable outcome of the pending governmental investigations or shareholder class action lawsuits, reputational harm caused by such investigations and lawsuits, the willingness of independent insurance agencies to outsource their computer and other processing needs to third parties; pricing and other competitive pressures and the Company’s ability to gain or maintain share of sales as a result of actions by competitors and others; changes in estimates in critical accounting judgments; changes in or failure to comply with laws and regulations, including accounting standards, taxation requirements (including tax rate changes, new tax laws and revised tax interpretations) in domestic or foreign jurisdictions; exchange rate fluctuations and other risks associated with investments and operations in foreign countries (particularly in Australia and India wherein we have significant operations); equity markets, including market disruptions and significant interest rate fluctuations, which may impede our access to, or increase the cost of, external financing; and international conflict, including terrorist acts.

Except as expressly required by the federal securities laws, the Company undertakes no obligation to update any such factors, or to publicly announce the results of, or changes to any of the forward-looking statements contained herein to reflect future events, developments, changed circumstances, or for any other reason.

Readers should carefully review the disclosures and the risk factors described in the documents we file from time to time with the SEC, including future reports on Forms 10-Q and 8-K, and any amendments thereto.

You may obtain our SEC filings at our website, www.ebix.com under the “Investor Information” section, or over the Internet at the SEC’s web site, www.sec.gov.


CONTACT:
Darren Joseph                                    
678 -281-2027 or IR@ebix.com

David Collins, Chris Eddy
Catalyst Global - 212-924-9800 or ebix@catalyst-ir.com
























Exhibit 99.1


Ebix, Inc. and Subsidiaries
Consolidated Statements of Income
(In thousands, except per share data)


 
Three Months Ended
 
Twelve Months Ended
 
December 31,
 
December 31,
 
2017
 
2016
 
2017
 
2016
 
(Unaudited)
 
(Unaudited)
 
(Unaudited)
 
(Audited)
 
 
Operating revenue
$
104,681

 
 
$
    80,046
 
 
$
363,971

 
 
$
298,294

 
Operating expenses:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cost of services provided
38,438
 
 
 
22,522
 
 
 
129,494
 
 
 
85,128
 
 
Product development
8,551
 
 
 
8,068
 
 
 
33,854
 
 
 
32,981
 
 
Sales and marketing
3,991
 
 
 
4,467
 
 
 
16,303
 
 
 
17,469
 
 
General and administrative (net)
17,820
 
 
 
14,670
 
 
 
59,976
 
 
 
51,689
 
 
Amortization and depreciation
2,800
 
 
 
2,658
 
 
 
11,123
 
 
 
10,746
 
 
Total operating expenses
71,600
 
 
 
52,385
 
 
 
250,750
 
 
 
198,013
 
 
 
 
 
 
 
 
 
Operating income
33,081
 
 
 
27,661
 
 
 
113,221
 
 
 
100,281
 
 
Interest income
97
 
 
 
632
 
 
 
1,711
 
 
 
1,851
 
 
Interest expense
(4,345
)
)
 
(1,995
)
 
 
(13,383
)
 
 
(7,376
)
 
Non-operating income - (loss)
 
 
 
 
 
 
 
 
 
1,162
 
 
Foreign currency exchange gain (loss)
(894
)
 
 
(839
)
 
 
1,811
 
 
 
13
 
 
Income before income taxes
27,939
 
 
 
25,459
 
 
 
103,360
 
 
 
95,931
 
 
Income tax expense
(414
)
 
 
(516
)
 
 
(777
)
 
 
(1,637
)
 
Net income including noncontrolling interest
27,525
 
 
 
24,943
 
 
 
102,583
 
 
 
94,294
 
 
Net income attributable to noncontrolling interest
952
 
 
 
314
 
 
 
1,965
 
 
 
447
 
 
Net income attributable to Ebix, Inc.
$
26,573

 
 
$
24,629

 
 
$
100,618

 
 
$
93,847

 
 
 
 
 
 
 
 
 
Basic earnings per common share
$
0.84

 
 
$
0.76

 
 
$
3.19

 
 
$
2.88

 
 
 
 
 
 
 
 
 
Diluted earnings per common share
$
0.84

 
 
$
0.76

 
 
$
3.17

 
 
$
2.86

 
 
 
 
 
 
 
 
 
Basic weighted average shares outstanding
31,470
 
 
 
32,279
 
 
 
31,552
 
 
 
32,603
 
 
 
 
 
 
 
 
 
 
Diluted weighted average shares outstanding
31,656
 
 
 
32,483
 
 
 
31,719
 
 
 
32,863
 
 






 
 
 
 
 
 
 
 
 
 
 














Exhibit 99.1

Ebix, Inc. and Subsidiaries
Consolidated Balance Sheets
 
December 31,
 2017
 
December 31,
 2016
 
(In thousands, except share and per share amounts)
ASSETS
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
63,895

 
 
$
114,118

 
Short-term investments
25,592
 
 
 
3,105
 
 
Restricted cash
4,040
 
 
 
0
 
 
Fiduciary funds- restricted
8,035
 
 
 
14,394
 
 
Trade accounts receivable, less allowances of $4,143 and $2,833, respectively
117,838
 
 
 
62,713
 
 
Other current assets
33,532
 
 
 
12,716
 
 
Total current assets
252,932
 
 
 
207,046
 
 
Property and equipment, net
41,704
 
 
 
37,061
 
 
Goodwill
666,863
 
 
 
441,404
 
 
Intangibles, net
45,711
 
 
 
41,336
 
 
Indefinite-lived intangibles
42,055
 
 
 
30,887
 
 
Capitalized software development costs, net
8,499
 
 
 
5,955
 
 
Deferred tax asset, net
43,529
 
 
 
31,345
 
 
Other assets
11,720
 
 
 
8,721
 
 
Total assets
$
1,113,013

 
 
$
803,755

 
LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
Current liabilities:
 
 
 
Accounts payable and accrued liabilities
$
75,073

 
 
$
30,461

 
Accrued payroll and related benefits
8,201
 
 
 
7,474
 
 
Cash overdraft
9,243
 
 
 
0
 
 
Fiduciary funds- restricted
8,035
 
 
 
14,394
 
 
Short term debt, net of deferred financing costs of $136
14,364
 
 
 
12,364
 
 
Contingent liability for accrued earn-out acquisition consideration
4,000
 
 
 
1,921
 
 
Current portion of long term debt and capital lease obligation
17
 
 
 
9
 
 
Deferred revenue
22,562
 
 
 
22,564
 
 
Current deferred rent
278
 
 
 
281
 
 
Other current liabilities
5,159
 
 
 
244
 
 
Total current liabilities
146,932
 
 
 
89,712
 
 
Revolving line of credit
274,529
 
 
 
154,029
 
 
Long term debt and capital lease obligation, less current portion, net of deferred financing costs of $298 and $452, respectively
110,978
 
 
 
105,824
 
 
Contingent liability for accrued earn-out acquisition consideration
33,096
 
 
 
6,589
 
 
Deferred revenue
1,423
 
 
 
1,886
 
 
Long term deferred rent
638
 
 
 
1,009
 
 
Other liabilities
11,658
 
 
 
6,070
 
 
Total liabilities
579,254
 
 
 
365,119
 
 
Commitments and Contingencies
 
 
 
 
 
 
 
Stockholders’ equity:
 
 
 
Convertible Series D Preferred stock, $.10 par value, 500,000 shares authorized, no shares issued and outstanding at December 31, 2017 and 2016
0
 
 
 
0
 
 



Exhibit 99.1

Common stock, $.10 par value, 60,000,000 shares authorized, 31,476,428 issued and outstanding at December 31, 2017 and 32,093,294 issued and outstanding at December 31, 2016
3,148
 
 
 
3,209
 
 
Additional paid-in capital
1,410
 
 
 
0
 
 
Retained earnings
510,975
 
 
 
457,364
 
 
Accumulated other comprehensive loss
(24,023
)
 
 
(33,677
)
 
Total Ebix, Inc. stockholders’ equity
491,510
 
 
 
426,896
 
 
Noncontrolling interest)
42,249
 
 
 
11,740
 
 
Total stockholders' equity
$
533,759

 
 
$
438,636

 
Total liabilities and stockholders’ equity
$
1,113,013

 
 
$
803,755

 


















































Exhibit 99.1

Ebix, Inc. and Subsidiaries
Consolidated Statements of Cash Flows

 
Year Ended December 31, 2017
 
Year Ended December 31, 2016
 
Year Ended December 31, 2015
 
 
(in thousands)
 
Cash flows from operating activities:
 
 
 
 
 
 
Net income attributable to Ebix, Inc.
$
100,618

 
 
$
93,847

 
 
$
79,533

 
 
Net income attributable to noncontrolling interest
1,965
 
 
 
447
 
 
 
0
 
 
 
Adjustments to reconcile net income to cash provided by operating activities:
 
 
 
 
 
 
Depreciation and amortization
11,123
 
 
 
10,746
 
 
 
10,634
 
 
 
Provision for doubtful accounts
1,713
 
 
 
1,515
 
 
 
3,111
 
 
 
Provision for deferred taxes, net of acquisitions and effects of currency translation
(13,667
)
 
 
(6,410
)
 
 
(10,143
)
 
 
Unrealized foreign exchange (gain)/losses
1,387
 
 
 
32
 
 
 
(1,743
)
 
 
Gain on investment interest in IHC/Ebix joint venture
 
 
 
(1,162
)
 
 
 
 
 
Amortization of capitalized software development costs
2,175
 
 
 
1,116
 
 
 
 
 
 
Share-based compensation
2,818
 
 
 
2,794
 
 
 
1,821
 
 
 
Debt discount amortization on convertible debt
 
 
 
 
 
 
17
 
 
 
Reduction of acquisition earn-out contingent liability
(164
)
 
 
(1,344
)
 
 
(1,533
)
 
 
Reduction of rent expense as a result of purchase accounting adjustment
(948
)
 
 
 
 
 
 
 
 
Changes in current assets and liabilities, net of acquisitions:
 
 
 
 
 
 
Accounts receivable
(34,245
)
 
 
(12,659
)
 
 
(7,320
)
 
 
Other assets
(2,133
)
 
 
(1,034
)
 
 
(3,834
)
 
 
Accounts payable and accrued expenses
8,906
 
 
 
(3,703
)
 
 
(19,895
)
 
 
Accrued payroll and related benefits
(3,979
)
 
 
170
 
 
 
(60
)
 
 
Deferred rent
(413
)
 
 
(234
)
 
 
(656
)
 
 
Reserve for potential uncertain income tax return positions
5,879
 
 
 
490
 
 
 
95
 
 
 
Liability - securities litigation settlement
 
 
 
 
 
 
(690
)
 
 
Other liabilities
252
 
 
 
(3,039
)
 
 
1,111
 
 
 
Deferred revenue
(4,480
)
 
 
2,176
 
 
 
(1,762
)
 
 
Net cash provided by operating activities
76,807
 
 
 
83,748
 
 
 
48,686
 
 
 
Cash flows from investing activities:
 
 
 
 
 
 
Investment in Paul Merchants
(37,398
)
 
 
 
 
 
 
 
 
Investment in Via, net of cash acquired
(67,835
)
 
 
 
 
 
 
 
 
Investment in Wall Street
(6,970
)
 
 
 
 
 
 
 
 
Investment in YouFirst, net of cash acquired
(9,657
)
 
 
 
 
 
 
 
 
Investment in beBetter
(1,000
)
 
 
 
 
 
 
 
 
Investment in ItzCash, net of cash acquired
(69,301
)
 
 
 
 
 
 
 
 
Payment of acquisition earn-out contingency, Qatarlyst
(1,921
)
 
 
 
 
 
 
 
 
Funding of escrow account for possible future contingent earn-out payment related to business acquisition
(4,040
)
 
 
 
 
 
 
 
 
Investment in Hope Health
 
 
 
(1,643
)
 
 
 
 
 
Investment in Wdev, net of cash acquired
 
 
 
(6,320
)
 
 
 
 
 
Investment in Via Media Health, net of cash acquired
 
 
 
 
 
 
(1,000
)
 
 
Investment in P.B. Systems, net of cash acquired
 
 
 
 
 
 
(11,475
)
 
 
Investment in EbixHealth JV, net of cash acquired
 
 
 
(696
)
 
 
(6,000
)
 
 
Purchases of marketable securities
 
 
 
(2,115
)
 
 
(1,435
)
 
 



Exhibit 99.1

Maturities of marketable securities
1,201
 
 
 
 
 
 
 
 
 
Capitalized software development costs
(2,805
)
 
 
(3,988
)
 
 
(3,489
)
 
 
Capital expenditures
(7,385
)
 
 
(5,977
)
 
 
(13,994
)
 
 
Net cash used in investing activities
(207,111
)
 
 
(20,739
)
 
 
(37,393
)
 
 
Cash flows from financing activities:
 
 
 
 
 
 
Proceeds from / (Repayment) to line of credit, net
120,500
 
 
 
(52,436
)
 
 
86,000
 
 
 
Proceeds from term loan
20,000
 
 
 
125,000
 
 
 
 
 
 
Principal payments on term loan obligation
(13,000
)
 
 
(6,250
)
 
 
(642
)
 
 
Cash overdraft
6,162
 
 
 
 
 
 
 
 
 
Repurchase of common stock
(45,732
)
 
 
(59,784
)
 
 
(81,653
)
 
 
Payments of long term debt
 
 
 
(600
)
 
 
 
 
 
Payments for capital lease obligations
(11
)
 
 
(5
)
 
 
(10
)
 
 
Excess tax benefit from share-based compensation
 
 
 
 
 
 
463
 
 
 
Proceeds from exercise of common stock options
52
 
 
 
824
 
 
 
2,209
 
 
 
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested
(398
)
 
 
(998
)
 
 
(2,202
)
 
 
Dividends paid
(9,545
)
 
 
(9,829
)
 
 
(10,472
)
 
 
Net cash provided (used) by financing activities
78,028
 
 
 
(4,078
)
 
 
(6,307
)
 
 
Effect of foreign exchange rates on cash and cash equivalents
$
2,053

 
 
$
(1,992
)
 
 
$
(107
)
 
 
Net change in cash and cash equivalents
(50,223
)
 
 
56,939
 
 
 
4,879
 
 
 
Cash and cash equivalents at the beginning of the year
$
114,118

 
 
$
57,179

 
 
$
52,300

 
 
Cash and cash equivalents at the end of the year
$
63,895

 
 
$
114,118

 
 
$
57,179

 
 
Interest paid
12,552
 
 
7,219
 
 
5,379
 
Income taxes paid
10,426
 
 
16,634
 
 
28,637